Phosphodiesterase 5 Inhibitor class drugs

22 results

  • adcirca

    (Tadalafil)
    United Therapeutics Corporation
    ADCIRCA® is indicated for treating pulmonary arterial hypertension (PAH) to improve exercise ability, specifically in patients with NYHA Functional Class II-III symptoms, including idiopathic, heritable PAH, and PAH associated with connective tissue diseases.
    Medication Details
    Drug Interactions

  • revatio

    (sildenafil citrate)
    PFIZER LABORATORIES DIV PFIZER INC
    REVATIO is indicated for treating pulmonary arterial hypertension (PAH) in adults and pediatric patients aged 1 to 17 years. It aims to improve exercise ability and delay clinical worsening in adults, while in pediatrics, it also addresses pulmonary hemodynamics when standardized exercise testing isn’t feasible.
    Medication Details
    Drug Interactions

  • sildenafil

    (Sildenafil)
    Quallent Pharmaceuticals Health LLC
    Sildenafil tablets, USP are indicated for treating pulmonary arterial hypertension (PAH) in adults, aimed at improving exercise ability and delaying clinical worsening. Pediatric usage information exists for a different formulation but is not included in this drug labeling due to marketing exclusivity.
    Medication Details
    Drug Interactions

  • sildenafil

    (Sildenafil)
    Ajanta Pharma USA Inc.
    Sildenafil for oral suspension is indicated for treating pulmonary arterial hypertension (PAH) in adults to improve exercise ability and delay clinical worsening. Pediatric information is available for a different formulation but not included in this product label due to marketing exclusivity.
    Medication Details
    Drug Interactions

  • sildenafil

    (Sildenafil)
    AvKARE
    Sildenafil tablets are indicated for the treatment of pulmonary arterial hypertension (PAH) in adults, aimed at improving exercise ability and delaying clinical worsening. Pediatric use information exists but is not included due to marketing exclusivity.
    Medication Details
    Drug Interactions

  • sildenafil citrate

    (Sildenafil)
    Advagen Pharma Ltd
    Sildenafil tablets are indicated for treating pulmonary arterial hypertension (WHO Group I) in adults, to enhance exercise ability and delay clinical worsening, particularly in those with NYHA Functional Class II-III symptoms. It should not be combined with bosentan, as it does not improve exercise capacity.
    Medication Details
    Drug Interactions

  • tadalafil

    (Tadalafil)
    Ajanta Pharma USA Inc.
    Tadalafil Tablets are indicated for treating pulmonary arterial hypertension (PAH) to enhance exercise capacity, particularly in patients with NYHA Functional Class II-III symptoms, including idiopathic, heritable PAH, and PAH linked to connective tissue diseases.
    Medication Details
    Drug Interactions